Senate Committee Lambastes Industry Response To FDA Year 2000 Initiative
This article was originally published in The Gray Sheet
Executive Summary
The lukewarm response by medical device manufacturers to FDA's call for information related to year 2000 compliance could jeopardize the industry's Y2K "shield" from liability claims, Sen. Christopher Dodd (D-Conn.) warned at a July 23 hearing of the Senate Special Committee on the Year 2000 Problem.